Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can neighbors deliver HIV care? cambodia trial puts community model to the test

NCT ID NCT04766710

Disease control Sponsor: National University of Singapore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers are studying whether trained community workers can safely deliver HIV treatment outside clinics in Cambodia. The trial enrolls about 4,000 people living with HIV who have stable treatment and no complications. Community action workers receive training to dispense drugs, check vital signs, and provide counseling. The goal is to see if this approach keeps more people in care, helps them stay virally suppressed, and reduces the workload at clinics.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Community-based antiretroviral therapy delivery by trained community action workers
What this could lead to
If it works, this model could help Cambodia and similar countries bring HIV treatment closer to patients, cut costs and travel, and ease pressure on clinics.
What could go wrong
The study is not a randomized controlled trial, so it may not prove cause and effect. Results from nine clinics in Cambodia may not apply elsewhere, and community delivery depends on training, supply chains, and local support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

4,049 people

The number who actually took part.

Started

Apr 2021

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Receiving ART for at least one year. 2. No adverse drug reactions or ARV drug interactions requiring regular monitoring. 3. No suspected or confirmed tuberculosis, no other opportunistic infections, and not on any prophylaxis. 4. Not pregnant/breastfeeding (for women). 5. Having a good understanding of lifelong treatment and adherence to the medication. 6. Presenting with evidence of treatment success: two consecutive undetectable viral load measures (or, in the absence of viral load monitoring, CD4 counts above 200 cells/mm3 and objective adherence measure). 7. Aged ≥15 years. 8. On the first-line ARV regimen. Exclusion criteria 1. Unstable people living with HIV as defined above 2. Mobile populations

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AIDS HIV infections

Contacts and locations

Locations

  • Cambodia Anti-Tuberculosis Association

    Phnom Penh, 2589-384, Cambodia

  • KHANA Center for Population Health Research

    Phnom Penh, 2361, Cambodia

  • National Center for Tuberculosis and Leprosy Control

    Phnom Penh, 2589, Cambodia

More trials for these conditions

Other studies related to the condition(s) this trial covers.